INTRODUCTION
Circulating granulocytes are partitioned in the blood between a marginating pool (MGP) and a circulating pool (CGP), which together make up the total blood granulocyte pool (TBGP) [l-61. The terms CGP, MGP and TBGP may refer to the whole body (prefix, w) or may be regional (prefix, r). Whereas the CGP is clearly a population within large blood vessels and the axial stream of small vessels, moving at the same speed as erythrocytes, the nature of the MGP is less clearly understood. Until recently it was regarded as a population of cells rolling slowly along the endothelial surface throughout the whole-body microvasculature, ready for migration into the tissues. However, it is also apparent that granulocytes undergo 'pooling' in several discrete and specific organs; i.e. exist in a regional circulation in excess of the numbers of erythrocytes compared with central blood [7-91. Similar pools are also recognized for platelets [lo-121. Furthermore, it is now known that margination, defined as endothelial rolling, is mediated by endothelial adhesion molecules, notably E-selectin [ 131, which are only expressed in inflammation. The notion, therefore, that granulocytes marginate and migrate diffusely throughout the tissues in normal subjects should be replaced by the concept of physiological regional pooling in specific organs. Margination should be viewed as a pathological process and is a term probably best avoided in the context of physiological studies [14-161, especially in the lung.
Several reviews have highlighted the lungs as an important site of physiological granulocyte pooling and suggested that the majority of the wTBGP is in the lungs, a claim that has been made for a range of species, including rabbit, dog and man, and a conclusion that has also been reached for monocytes [18, 191 and lymphocytes [19-211. Nevertheless, since leucocyte labelling became a routine diagnostic imaging procedure [22-251, it is difficult to avoid the impression that, in contrast, the lungs of normal human subjects are only modestly engaged in physiological granulocyte pooling. The aims of this article, therefore, are to review the experimental evidence in favour of granulocyte pooling in the lungs, to review human observations which in general have not supported the experimental findings, and finally to examine possible ways to reconcile the conflicting data.
observations on granulocyte deformability and retention in artificial membranes, ex vivo studies on isolated perfused lungs, morphometry of pulmonary capillaries and granulocytes, direct observation through chest wall windows, and physiological studies of granulocyte kinetics using both native and radiolabelled blood cells (Table 1) .
In vitro and ex vivo studies
Although their diameter is similar to that of granulocytes and slightly greater than that of pulmonary capillaries, erythrocytes are not delayed in the lungs because they are highly deformable. Several studies have looked at the deformability characteristics of granulocytes in vifro and their retention in membranes with pores of a size comparable to pulmonary capillary diameter. Neutrophil retention in such membranes decreases with increasing perfusate pressure, perfusate flow rate and perfusate haematocrit [26] , suggesting that retention in pulmonary capillaries, and subsequent release, may largely be mechanical phenomena. Monocytes are slightly larger than neutrophils, lymphocytes slightly smaller, and their retentions correlate with cell size [27] . Neutrophils can be made more stiff by exposure to glutaraldehyde, without affecting their adhesiveness or size, after which they show greater retention in filters [27] .
The isolated perfused rabbit lung has been used as a model for studying pulmonary vascular granulocyte traffic. At physiological perfusate flow rates, Schutte et al. [28] found that about 20% of "'In-labelled granulocytes injected into the afferent perfusate were recovered immediately in the pulTabk l. Mahods for quantifying pulmonary granulocyte traffic monary vein along with 99% of simultaneously injected labelled erythrocytes. The remaining 80% washed out of the lung monoexponentially with a f112 of 8 min. A decrease in flow rate lengthened the f1/2 but had no effect on the size of the fraction undergoing rapid initial transit. Increasing flow rate affected neither f1/2 nor fraction size. Mean granulocyte transit time was about 50 times that of erythrocytes, a value in agreement with several morphometric studies (see below).
Direct Observations
Direct videomicroscopic observations of granulocyte traffic in subpleural pulmonary tissue through chest wall windows in dogs after intravenous injection of granulocytes labelled with fluorescein isothiocyanate-dextran showed a wide range of vascular transit times with a frequency distribution skewed towards short times [29, 301. Granulocytes were arrested in pulmonary capillaries for periods of several minutes, even up to 20min. Lien et al. [30] reported that, under basal conditions, about 50% of granulocytes arriving in the lung negotiated pulmonary capillaries without any impedance, moving at the same speed as erythrocytes, while the remainder were completely arrested. Eventually these immobilized cells suddenly dislodged and accelerated away either to leave the lung without further obstruction or occasionally to become obstructed again in a capillary downstream. The fraction of cells showing no episodes of immobilization was higher in conditions of high pulmonary flow and lower after balloon inflation in the inferior vena cava. 
Method

Physiological studies
Physiological studies which avoid the use of radiolabelled cells, and which therefore avoid the tricky assumption that labelled cells behave identically to native cells, are also consistent with pulmonary vascular granulocyte pooling. These studies have in general looked at the transient pulmonary arteriovenous granulocyte concentration gradients that can be generated by various physiological manoeuvres, including forced expiration against an occluded airway [20] showed that after an abrupt decrease in cardiac output by inflation of a balloon in the inferior vena cava, the left ventricular neutrophil count immediately decreased and was followed 20-30s later by a decrease in right ventricular neutrophil count and further widening of the arteriovenous difference. The gradient stabilized after a few minutes, consistent with a new equilibrium. Restoration of blood flow after prolonged periods of balloon inflation was accompanied by a large rebound neutrophilia, suggesting release of neutrophils pooled elsewhere as a result of systemic hypoperfusion.
Radiolabelled blood cells
Radiolabelled granulocytes given in conjunction with labelled erythrocytes for measuring erythrocyte transit time and regional pulmonary blood volume, Radioactive studies have been combined with morphometric studies to estimate pulmonary granulocyte transit time without having to use radiolabelled granulocytes. Hogg et al. [31] gave patients who were about to undergo lung resection W rlabelled erythrocytes as a marker of pulmonary blood volume and 99mTc-macroaggregated albumin as a marker of blood flow. Radioactivity was measured in lung slices after resection. Blood cell concentration in capillary blood (cells/ml) was determined morphometrically and divided by cell inflow (cells s-I ml-l) to give cell transit times. Capillary blood volume was estimated to be about 180 ml, or 40% of pulmonary blood volume, giving mean capillary transit times estimated to be 3 s for erythrocytes and 190 s for granulocytes.
The idea that granulocytes are delayed by mechanical entrapment in pulmonary capillaries is supported by (i) observations relating retention to pulmonary blood flow and to erythrocyte transit times, (ii) an inverse relationship between pulmonary blood flow and granulocyte transit time, and (iii) an increase in transit times in response to manoeuvres which cause capillary narrowing. It is further strengthened by the association between increased granulocyte transit time and decreased granulocyte deformability, produced by treatment with lipopolysaccharide (LPS) Of several studies showing decreased granulocyte deformability in response to cytokines, one of the most illuminating is based on the measurement of granulocyte deformability using an instrument called a cell poker [50] . Granulocytes exposed to N-formylmethionyl-leucyl-phenylalanine have increased stiffness and a prolonged pulmonary transit time but behave like normal cells when their cytoskeletal assembly mechanism is first blocked with cytochalasin D. Similarly, granulocytes exposed to glutaraldehyde in vifro are stiff to the cell poker, are retained in filters in vitro and show delayed transit through the rabbit lung in vivo [27] . An observation in humans which echoes these findings is a correlation between the first-pass retention of "'In-labelled granulocytes and their 'filterability' through micropore membranes [51].
CRITICAL ANALYSIS OF EXPERIMENTAL DATA
The foregoing represents an impressive body of data in favour of a large pulmonary vascular granulocyte pool but contrasts alarmingly with routine observations made in patients undergoing diagnostic leucocyte scintigraphy. If the pool is as large as suggested, the lungs should remain very prominent on scintigraphy for as long as labelled cells remain in the circulation. However, apart from an early transient prominent lung signal, this is not the case.
The size of a cell pool (i.e. rTBGP) is equal to the product of the mean transit time through it and regional cell inflow rate (i.e. blood flow). As mean circulation time is 1 min (i.e. total blood volume/ cardiac output), mean granulocyte transit time through the wCGP is also about 1 min, assuming that granulocytes in the axial capillary stream move at the same speed as erythrocytes. A mean capillary transit time in the lung of 3 min, therefore, implies that the pulmonary rTBGP is three times the size of the wCGP. This would mean that the size of the wCGP could be no more than 25% of the wTBGP. This is clearly at variance with the size of the wCGP in dog and man of about 50% of wTBGP, measured with granulocytes labelled with 32P [l-51 or in vivo with tritiated thymidine [4-61 ( Table 2 ). In the videomicroscopic studies of Lien et al. [29, 301, the circulating activity was 33% of the dose at 2min after injection, falling to about 20% at 30 min, and the average time spent by granulocytes in pulmonary capillaries appeared to be 6 min. Although small compared with measurements based on tritiumlabelled cells, a wCGP of 20% of wTBGP would be consistent with a mean pulmonary transit time of 6 min. Nevertheless, it is difficult to dispute the existence of significant granulocyte pooling elsewhere, especially in the spleen, bone marrow and iiver (see below), and if allowance is made for these organs then the discrepancy between the postulated size of the pulmonary pool and the wCGP becomes 
EVIDENCE AGAINST A MAJOR PULMONARY GRANULOCYTE POOL
Evidence against the lung and in favour of alternative sites with respect to granulocyte pooling is based on several sets of observations in humans, mostly using radiolabelled cells.
Extrapulmonary granulocyte kinetics
Pioneering work with tritiated granulocytes labelled in vivo demonstrated that the wCGP is more than 50% of the wTBGP in both dogs and man [4, 51, and more than 30% in rabbits [6] . A pulmonary granulocyte pool three times the wCGP is not compatible with these values. As tritiated cells are not exposed to any in vitro manipulation, they should be regarded as the gold standard against which to compare cells labelled in vitro. The Hammersmith group [%, 25, 53, 61-63] has shown that in man the recovery in the circulation at 40min of both "'In-and %Tc-labelled granulocytes is 35-40%, which, taking into account physiological granulocyte destruction up to 40 min, represents a minimum value for the wCGP. Although this is still probably less than the true wCGP, experimental studies aiming to quantify the pulmonary rTBGP in dogs and rabbits have consistently obtained intravascular recoveries at 10 min of only about 10% [19,41, 42, 441, strongly suggesting unphysiological behaviour of labelled granulocytes.
The spleen, liver and bone marrow are prominent in humans after injection of labelled granulocytes. In early clinical studies, it was obvious that the greater the initial lung sequestration, the greater the liver uptake that soon followed and the lower the recovery of cell-associated radioactivity in the circulation There is substantial evidence in favour of the spleen as a major site of granulocyte pooling [7-9, 61, 64-69]. In early studies it was shown that after adrenaline infusion the arterial granulocyte count increased before the central venous count, consistent with release of cells from the lungs [40] . Adrenaline given directly into the splenic artery also produced an early rise in arterial granulocyte count but this was followed later by a relative granulocytosis in hepatic venous blood [MI. This would probably have occurred later anyway with intravenous adrenaline. Thus, using SICr-labelled granulocytes and surface counting, McMillan and Scott [69] showed a fall in counts over the spleen and a simultaneous rise in blood activity in normal subjects after intravenous infusion of adrenaline. A delay in hepatic venous granulocytosis fits well with more recent studies using "'In-labelled granulocytes and wmTc-labelled erythrocytes in which a delayed peripheral granulocytosis after strenuous exercise coincided with a decrease in splenic granulocyte activity [8] (Fig. 2) . Splenic erythrocyte activity, in contrast, fell immediately after exercise, and recovered with a time course consistent with the much more rapid transit time of erythrocytes through the spleen. As a result of the longer intrasplenic transit time of granulocytes, about lOmin, a new equilibrium in response to haemodynamic changes would be delayed, as suggested by Allsop et al. [8] , who, on the basis of these divergent intrasplenic kinetics of erythrocytes and granulocytes, concluded that exercise probably induced granulocytosis by reducing splenic blood flow. Exercise produced a virtually identical response with respect to "'In-labelled platelets, which are known to pool in the spleen with a transit time of 10 ] have shown pooling characteristics in the bone marrow similar to those in the spleen. Deconvolution analysis using output curves from spleen and lumbar spine gave almost identical impulse response curves.
It is impossible from clinical studies to avoid the strong impression that the physiological scenario is lcyte pod 13 minimal lung and liver activity combined with maximal splenic activity. Increased pulmonary activity induced by activation in vitro clears over about Wmin in association with an increasing, albeit low, circulating activity and with liver and spleen timeactivity curves which increase progressively in parallel. It seems that the cells, once they are washed out of the lung, are unable to recirculate and are removed non-specifically by the reticuloendothelial system. It is inconceivable that normal granulocyte behaviour is typified by high lung and liver activity in association with a low recovery in the circulation. These proposals fit with those animal studies which have specifically looked at the effects of cell activation on pulmonary granulocyte kinetics in associa- extent that recovery in the general circulation was almost zero [53] .
Measurement of pulmonq vascular granulocyte transit time
Several techniques based on labelled granulocytes have been described for the measurement of the size of the pulmonary rTBGP in humans ( Tables 1, 3 and 4), including simple approaches such as the half-time of decrease in the pulmonary time-activity curve after intravenous injection [81] and comparison of stable count rates over the lung with simultaneous count rates over the liver and/or spleen as soon as equilibrium is established between blood and regional pools [82, 831. Using more rigorous approaches, the pulmonary granulocyte pool can be expressed as the granulocyte transit time, without necessarily implying any mechanism of transit, in several different ways. These include (i) the transit time measured in absolute time units by deconvolution analysis If the pulmonary circulation is replete with pooled granulocytes, it should be relatively easy to demonstrate a decrease in the pool in response to an appropriate stimulus. In contrast to the study of Muir et al. [59] , Peters et al. [58] were unable to demonstrate any release of lllIn-labelled granulocytes from the lungs in response to exercise. An important difference compared with the study of Muir et al. [59] was that the labelled cells were injected before exercise. Equilibration throughout the wTBGP was considered complete when the splenic signal had stabilized on dynamic imaging at 30 min after injection. After exercise, the volunteer was returned to the supine position and dynamic imaging continued for a further 40 min. Whereas granulocyte release from the spleen was striking with a characteristic time course consistent with the long physiological intrasplenic transit time of granu-CGP locytes (approx. lOmin), the pulmonary signal increased in proportion to the physiological neutrophilia (native equal to radiolabelled cells) resulting from the exercise. Very similar kinetics were observed with ll'In-labelled platelets which have a similar intrasplenic transit time. In Muir's protocol, the labelled cells were injected immediately before exercise, with the result that equilibration of the granulocytes occurred pun pussu with the demarginating effects of exercise. Furthermore, exercise took place at a time when labelling-induced activation (perhaps reversible) may have been present. Given the effects of pulmonary blood flow on the likelihood of granulocyte immobilization in pulmonary capillaries, it is easy to imagine how granulocytes activated in vitro, and presumably therefore less deformable, could be forced through pulmonary capillaries by the increased blood flow of exercise.
Effect of inhalation of potential stimulators
MacNee et al. [86] demonstrated the effects of acute cigarette smoking on pulmonary neutrophil kinetics, and argued in favour of a role for increased pulmonary neutrophil retention in the aetiology of lung damage associated with smoking. Again, how- ever, the stimulus, one or two rapidly smoked cigarettes, coincided with the injection of "'In-labelled neutrophils. Compared with non-smokers, the pulmonary time-activity curve fell to an asymptotic value at 40 min less rapidly in subjects who smoked at the time of injection, implying prolongation of cell transit. Any effect that smoking may have exerted on splanchnic haemodynamics could have influenced the pulmonary time-activity curves as a result of reduced pooling of labelled cells in the liver and/or spleen and therefore a higher pulmonary rCGP. Nevertheless, smoking also resulted in an increased first-pass retention which should be independent of subsequent cell kinetics elsewhere.
It has been relatively easy to demonstrate an increase in pulmonary neutrophils in response to the inhalation of PAF, which causes neutropenia after inhalation as an aerosol. Tam et al. [60] showed that the neutropenia was associated with a simultaneous increase in pulmonary radioactivity when PAF was inhaled 40 min after intravenous injection of 'In-labelled granulocytes. The count rate over the lung doubled within 5 min of PAF inhalation concomitant with a sharp decrease in both the peripheral neutrophil count and the concentration of cell-associated "'In. Masclans et al. [87] demonstrated that inhalation of PAF at the time of "'In-neutrophil injection resulted in a higher firstpass lung retention in patients pretreated with vehicle compared with salbutamol which prevents the neutropenia of PAF inhalation. Interestingly, unlike the earlier smoking study of MacNee et al.
[86], PAF inhalation resulted in no difference in cell washout rates from the lungs between subjects pretreated with vehicle compared with subjects pretreated with salbutamol, reinforcing the view that increased granulocyte retention in the lung may not necessarily be accompanied by delayed washout because of the simultaneous effects on cell kinetics elsewhere. PAF appeared to have little effect on the stable liver and spleen curves in the study of Tam et al. [60] but since the increase in circulating granulocytes induced by PAF would have produced a passive increase in the liver and spleen signals, PAF probably had a demarginating effect in the liver and spleen.
Observations in disease
If most of the wTBGP normally resides in the pulmonary circulation, then some difficulty might be anticipated in demonstrating an increase in the pulmonary granulocyte pool in disease. This, however, has not been the case. There are several diseases, including inflammatory bowel disease, systemic vasculitis and graft-versus-host disease, in which an expanded pulmonary rTBGP is clearly visible during labelled leucocyte scintigraphy, up to about three times the normal level [76, 82, 83, 851. The kinetics of this increased signal are quite different from those seen when the cells have been activated or damaged in vitro [53] . Firstly, the distribution between liver and spleen remains physiological insofar as liver activity reaches an early plateau and is minimal, and secondly, the pulmonary signal is sustained in parallel with the circulating radioactivity. The pathophysiological pooling seen in systemic inflammation is not associated with overt lung injury and clears by 24 h, unlike uptake at sites of inflammation where the signal increases up to 24 h [24, 811. Consistent with a mean residence time in blood of about 10 h, radiolabelled granulocytes disappear from blood by 24 h in parallel with the pulmonary activity, implying that the pulmonary granulocytes remain intravascular and do not migrate into the lung parenchyma. The mechanism leading to delay in the pulmonary capillaries, whether induced by the pulmonary endothelium or the result of a change in the granulocyte itself, is not certain, although it has been shown (Ussov W, Peters AM, Myers MJ and Hughes JMB, unpublished work) that the fraction of cells comprising the slow exponential of the biexponential impulse response curve generated by deconvolution analysis correlated with the fraction of cells in the injected sample showing shape change, implying a change in the granulocyte itself. On the other hand, Carpani de Kaski et al. [88] showed that the increased lung signal in inflammatory bowel disease was unchanged after successful treatment with oral non-absorbable steroids, implying a pulmonary endothelial mechanism.
CONCLUSIONS
It is difficult to reconcile clinical imaging data with the foregoing experimental data. Two crucial factors must be taken into account when comparing and contrasting the two perspectives: firstly, it is hazardous to consider kinetics in any one organ in isolation from the rest of the body; and secondly, consideration must be given to the possibility that any quantitative result may be the result of a labelling artefact. The single variable most sensitive to labelling-induced changes is the percentage of the injected granulocyte-associated activity circulating in blood as granulocyte-associated activity after equilibration throughout the intravascular space, usually 30-40 min after injection. In relation to this, it is indisputable that the wCGP is at least 40% of wTBGP. Several pieces of evidence indicate that, in man, the spleen and bone marrow are significant sites of pooling, probably totalling at least 30% of the wTBGP. Pooling within the liver is difficult to quantify because, as in the lung, granulocyte transit time is a sensitive marker of in vitro activation. So, even before considering the lung, about 70% of the wTBGP has already been accounted for.
With the possible exception of sheep [89], it seems clear from the experimental literature that pulmonary granulocyte pooling takes place in capil-laries. One factor which may account for the difference in clinical and experimental findings is that gamma camera scintigraphy includes a significant signal from labelled granulocytes circulating in vessels other than capillaries. Indeed, the capillary blood volume has been variously estimated to be between 70 and 200m1, or about 15-40% of total pulmonary blood volume. The transit time recorded by scintigraphy may therefore be 'diluted' by granulocytes moving at the same speed as erythrocytes in extra-capillary vessels. This, however, offers only a marginal explanation since if mean capillary granulocyte transit time was 3 min, the signal recorded by a gamma camera from capillaries would dwarf that from larger vessels. A value of 3 min would, as explained above, indicate that the pulmonary pool is at least three times the wCGP, 10% of which would be the pulmonary rCGP. Thus rCGP would only represent 1/30 of the pulmonary rTBGP. Looking at it from the opposite perspective, gamma camera studies at cell equilibrium suggest a global pulmonary granulocyte transit time of 3-5 times that of erythrocytes. Erythrocyte transit time is 5 s (i.e. pulmonary blood volume/cardiac output, but confirmed by direct measurement), of which 3-4 s is in vessels other than capillaries. As global granulocyte transit time would be 15-25 s by comparison with erythrocytes, intra-capillary granulocyte transit time could be 14-24 times longer than capillary erythrocyte transit time if the latter was 1 s. This argument at least bridges some of the gap between imaging and experimental studies.
As in any experimental study, discordant results compared with man may result from species differences. According to Doerschuk et al. [34] , human granulocytes deform more rapidly than those of the dog and rabbit. Furthermore, a smaller fraction of human pulmonary capillaries have smaller diameters than granulocytes than is the case in dogs and rabbits, a fraction which correlates with the first-pass lung retentions of labelled granulocytes in these three species. However, of critical importance, labelled granulocyte recoveries in the general circulation, which represent measures of the wCGP/ wTBGP, are indistinguishable between dogs and humans when based on tritiated cells [4, 51. Although the ratio is somewhat less in rabbits [6] , species differences seem unable to bridge the gap between human clinical studies and experimental findings.
The best opportunity to close the discrepancy lies in the notion of the existence in the pulmonary vascular bed of two separate discrete populations of cells, one freely moving at the same speed as erythrocytes, the other immobilized for variable periods of time. As stressed by several groups, only a tiny percentage of pulmonary capillaries (approx. 2%) need to be obstructed to produce significant immobilization (approx. 50%), so there is no significant secondary obstruction to erythrocytes. Because cells which are not immobilized move rapidly, it is conceivable that they are not counted, either on videomicroscopy or pulmonary morphometry. Mean transit times in the range 3-6min would then only apply to immobilized cells and the effective size of the entire pulmonary population would depend on the fraction that was immobilized at any time point. Lien et al. [30] estimated that 50% of granulocytes passed through the lung entirely unobstructed, whereas on the basis of the indicator dilution technique Hog's group [39] would put the obstructed population at 80-90% (Table 4) . A value of 30% (reasonably close to Lien) with a mean obstruction time of 1.5 min (reasonably close to Hogg) could be more easily fitted into a global picture of wholebody granulocyte distribution in which splenic and bone marrow blood flow combined was 400mUmin and transit time 8min, and liver blood flow, 1200 ml/min and transit time 0.5 min (Fig. 3) . A mean circulation time of 1 min and a cardiac output of 5 litres/min would then give a value for wCGP of 36% of wTBGP, a pulmonary rTBGP of 28% of wTBGP, and an extrapulmonary pool of 40% of wTBGP. So, in conclusion, the pulmonary granulocyte pool is big, but not as big as portrayed in the experimental literature.
